FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Scopolamine Transdermal System
Status: Resolved
»Duration of Shortage: 08/27/2018 - 12/10/2019
»Therapeutic Categories: Endocrinology/Metabolism; Neurology

Expand all

GlaxoSmithKline (Revised 12/11/2019)

Company Contact Information:
908-293-5330

Presentation
  • Transderm (Scopolamine) 1.5 mg Patch 10 count (NDC 10019-553-03)
  • Transderm (Scopolamine) 1.5 mg Patch 24 count (NDC 10019-553-04)
  • Transderm (Scopolamine) 1.5 mg Patch 4 count (NDC 66758-208-54)
Note:
  • N/A

Mylan Pharmaceuticals Inc. (Revised 12/10/2019)

Company Contact Information:
800-796-9526

Presentation
  • 1 mg/3 days 4s (NDC 0378-6470-99)
  • 1 mg/3 days 10s (NDC 0378-6470-97)
  • 1 mg/3 days 24s (NDC 0378-6470-44)
Note:
  • N/A

Perrigo Pharmaceuticals (Revised 12/11/2019)

Company Contact Information:
866-634-9120

Presentation
  • Scopolamine Transdermal System, 1mg/3days 4-Count Pack (NDC 45802-580-84)
  • Scopolamine Transdermal System, 1mg/3days 10-Count Pack (NDC 45802-580-46)
  • Scopolamine Transdermal System, 1mg/3days 24-Count Pack (NDC 45802-580-62)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English